|
|
|
|
An Analysis of Minor Variants in HIV-1 Integrase (IN) for Subjects With Only Historic Evidence of Integrase Inhibitor (INI) Resistance Enrolled in Study ING112574 (VIKING-3) (slide presentation, poster to follow)
|
|
|
Reported by Jules Levin
International Workshop on Antiviral Drug Resistance
June 3-7 2014, Berlin, Germany
R Paredes,1 M Noguera-Julian,1 C Pou,1 J Horton,2
K Remlinger,2 C Vavro2
1IrsiCaixa AIDS Research Institute and HIV Unit, Hospital Germans Trias i Pujol, Catalonia, Spain; 2GlaxoSmithKline, Research Triangle Park, NC, USA
|
|
|
|
|
|
|